Argenta is a trusted strategic partner with significant industry experience in providing contract small molecule drug discovery services. Argenta offers a truly integrated approach to undertaking complete drug discovery programmes as well as hit identification, hit-to-lead, and lead optimisation projects. Our industry-seasoned, multi-disciplinary research teams work closely with our clients' scientists to enhance knowledge, add manpower, shorten time to development candidate identification, and increase the value of their drug discovery programmes.
| Website | http://www.argentadiscovery.com |
| Revenue | $24.1 million |
| Employees | 48 (13 on RocketReach) |
| Founded | 2000 |
| Industry | Pharmaceuticals, Drug discovery services, Integrated drug discovery, Respiratory drug discovery |
| Web Rank | 149139 |
| Web Visits | 414860 |
| Keywords | Drug Discovery, Drug Design, Small Molecule, Contract Research, Pharmaceutical Services, Biopharmaceutical Services, Hit Identification, Drug Candidate Identification, Lead Optimization, Medicinal Chemistry, Lead Generation, Drug Development, In Vitro Studies, Preclinical Development, In Vivo Studies, Pharmacokinetics, Pharmacodynamics |
| Competitors | Covance, Syneos Health, ICON plc, Charles River Laboratories, Shanghai Medicilon Inc., Celerion, WuXi AppTec, Envigo ++++, Research Pharmaceutical Services +40 more (view full list) |
Looking for a particular Argenta Discovery employee's phone or email?
The Argenta Discovery annual revenue was $24.1 million in 2026.
13 people are employed at Argenta Discovery.
Argenta Discovery is based in Harlow, Essex.